Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10583-10599
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10583
Table 6 Results of 16S rRNA gene-based fecal microbiota profiling in serial fecal samples of the neonate
POD (DOL)
Class level
Family level
Genus level
Before surgical treatment of CHD (DOL 7) – feeding with fortified BM with preterm formula added (because of low BM supply)
- (7)Negativicutes 44.9%Veillonellaceae 44.9%Veillonella 44.9%
Gammaproteobacteria 41.1%Enterobacteriaceae 38.8% Pasteurellaceae 2.3%Escherichia/Shigella 38.8%
Bacilli 12.3%Streptococcaceae 8.0% Enterococcaceae 4.3%Streptococcus 8.0% Enterococcus 4.3%
Before surgical treatment of CHD (DOL 14) – before the first episode of NEC stage IIA on POD 1 (DOL 15) Feeding with fortified BM with preterm formula added (because of low BM supply)
- (14)Clostridia 57.8%Clostridiaceae 57.8%Clostridium sensu stricto I 57.8% 1Clostridium paraputrificum 56.1%
Gammaproteobacteria 29.6%Enterobacteriaceae 24.8% Pasteurellaceae 4.8%Escherichia/Shigella 24.8% Actinobacillus 4.8%
Bacilli 5.7%Streptococcaceae 5.7%Streptococcus 5.7%
Actinobacteria 3.8%Bifidobacteriaceae 3.8%Bifidobacterium 3.8%
Negativicutes 3.1%Veillonellaceae 3.1%Veillonella 3.1%
POD 8 (DOL 22) – after ampicillin/sulbactam therapy (POD 1-7) and metronidazole therapy (POD 2-6) had been completed and piperacillin/tazobactam therapy was started (POD 7-14) (nil per os)
8 (22)Gammaproteobacteria 99.8%Enterobacteriaceae 99.8%Escherichia/Shigella 99.8%
Clostridia 0.2%Ruminococcaceae 0.2%1Ruminococcus bucirculans 0.2%
POD 21 (DOL 35) – 7 d after the antibacterial therapy was completed on POD 14 Feeding with hydrolyzed formula
21 (35)Clostridia 58.0%Clostridiaceae 56.9% Lachnospiraceae 1.1%Clostridium sensu stricto I 56.9% Anaerostripes 1.1%
Gammaproteobacteria 38.7%Enterobacteriaceae 38.7%Escherichia/Shigella 38.7%
Bacilli 3.2%Enterococcaceae 3.2%Enterococcus 3.2%
POD 29 (DOL 43) – on the day after onset of the second episode of NEC IIA Feeding before NEC IIA onset: Expressed BM (from DOL 37) with hydrolyzed formula dotation
29 (43)Clostridia 72.0%Clostridiaceae 72.0%Clostridium sensu stricto I 72.0%
Gammaproteobacteria 22.7%Enterobacteriaceae 19.8% Pasteurellaceae 2.9%Escherichia/Shigella 18.1%
Negativicutes 5.3%Veillonellaceae 5.3%Veillonella 5.3%

  • Citation: Kaplina A, Zaikova E, Ivanov A, Volkova Y, Alkhova T, Nikiforov V, Latypov A, Khavkina M, Fedoseeva T, Pervunina T, Skorobogatova Y, Volkova S, Ulyantsev V, Kalinina O, Sitkin S, Petrova N. Intestinal microbiome changes in an infant with right atrial isomerism and recurrent necrotizing enterocolitis: A case report and review of literature. World J Clin Cases 2022; 10(29): 10583-10599
  • URL: https://www.wjgnet.com/2307-8960/full/v10/i29/10583.htm
  • DOI: https://dx.doi.org/10.12998/wjcc.v10.i29.10583